Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
125.81
+0.58 (0.46%)
At close: Aug 10, 2026, 4:00 PM EDT
126.57
+0.76 (0.60%)
After-hours: Aug 10, 2026, 7:34 PM EDT

Encompass Health Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Encompass Health stock has a consensus rating of "Strong Buy" and an average price target of $148.17. The average 1-year stock price forecast is 17.77% higher than the current stock price, while the lowest is $140 (+11.28%) and the highest is $155 (+23.20%).

Price Target: $148.17 (+17.77%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$140$148.17$150$155
Change+11.28%+17.77%+19.23%+23.20%

Analyst Ratings

The average analyst rating for Encompass Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy111112121212
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total121213131313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Buy
Reiterates
$125$140
BuyReiterates$125$140+11.28%Aug 10, 2026
Raymond James
Raymond James
Buy
Maintains
$130$150
BuyMaintains$130$150+19.23%Aug 7, 2026
UBS
UBS
Buy
Reiterates
$150$155
BuyReiterates$150$155+23.20%Aug 7, 2026
Truist Financial
Truist Financial
Buy
Reiterates
$140$150
BuyReiterates$140$150+19.23%Aug 6, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$150$153
BuyReiterates$150$153+21.61%Aug 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
6.46B
from 5.94B
Increased by 8.84%
Revenue Next Year
6.99B
from 6.46B
Increased by 8.26%
EPS This Year
6.11
from 5.45
Increased by 12.17%
EPS Next Year
6.68
from 6.11
Increased by 9.24%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
4.01B4.35B4.80B5.37B5.94B6.46B
Revenue Growth
12.58%8.31%10.41%11.91%10.46%8.84%
Gross Profit
1.70B1.75B1.98B2.23B2.56B2.71B
Gross Margin
42.43%40.32%41.30%41.56%43.22%41.90%
Operating Income
659.40M630.20M731.80M874.90M1.05B1.05B
Net Income
412.20M271.00M352.00M455.70M566.20M634.78M
EPS
----5.456.11
EPS Growth
----23.02%12.17%
Forward PE
14.9918.9518.1220.0918.9120.58
Dividend / Share
1.120.860.600.640.720.79
Dividend Growth
--23.21%-30.23%6.67%12.50%10.18%
Free Cash Flow
-73.86M-3.34M123.69M215.84M296.79M485.50M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High6.5B
Avg6.5B
Low6.4B

Revenue Growth

Revenue Growth202620272028
High
9.1%
Avg
8.8%
Low
8.5%

EPS Forecast

EPS202620272028
High6.20
Avg6.11
Low5.84

EPS Growth

EPS Growth202620272028
High
13.7%
Avg
12.2%
Low
7.2%